OBJECTIVE: To determine the relationship between first-phase (1 minute + 3 minutes) insulin production during the intravenous glucose tolerance test (IV-GTT) and risk factors for developing type 1 diabetes. STUDY DESIGN: Relatives of persons with type 1 diabetes (n = 59,600) were screened for islet cell antibodies (ICAs). Subjects who had positive screening results underwent IV-GTT (> or =2 times), repeat ICA screening, insulin autoantibody (IAA) screening twice, and an oral glucose tolerance test. RESULTS: Of the 59,600 subjects in the study, 2199 (3.69%) had positive findings on initial ICA test. IV-GTTs were performed in 1622 subjects, with children <8 years having the lowest first-phase insulin release (FPIR) and subjects 8 to 20 years of age having the highest FPIR. The FPIR was lower for subjects with a confirmed positive ICA test result or a positive IAA test result, subjects with higher titers of ICA or IAA, and subjects who had an abnormal (impaired or diabetic) oral glucose tolerance test result. CONCLUSION: FPIR in the IV-GTT correlates strongly with risk factors for development of type 1 diabetes.
OBJECTIVE: To determine the relationship between first-phase (1 minute + 3 minutes) insulin production during the intravenous glucose tolerance test (IV-GTT) and risk factors for developing type 1 diabetes. STUDY DESIGN: Relatives of persons with type 1 diabetes (n = 59,600) were screened for islet cell antibodies (ICAs). Subjects who had positive screening results underwent IV-GTT (> or =2 times), repeat ICA screening, insulin autoantibody (IAA) screening twice, and an oral glucose tolerance test. RESULTS: Of the 59,600 subjects in the study, 2199 (3.69%) had positive findings on initial ICA test. IV-GTTs were performed in 1622 subjects, with children <8 years having the lowest first-phase insulin release (FPIR) and subjects 8 to 20 years of age having the highest FPIR. The FPIR was lower for subjects with a confirmed positive ICA test result or a positive IAA test result, subjects with higher titers of ICA or IAA, and subjects who had an abnormal (impaired or diabetic) oral glucose tolerance test result. CONCLUSION: FPIR in the IV-GTT correlates strongly with risk factors for development of type 1 diabetes.
Authors: P Achenbach; K Warncke; J Reiter; A J K Williams; A G Ziegler; P J Bingley; E Bonifacio Journal: Diabetologia Date: 2006-09-26 Impact factor: 10.122
Authors: Jennifer M Barker; Kim McFann; Leonard C Harrison; Spiros Fourlanos; Jeffrey Krischer; David Cuthbertson; H Peter Chase; George S Eisenbarth Journal: J Pediatr Date: 2007-01 Impact factor: 4.406
Authors: Peter Buchwald; Alejandro Tamayo-Garcia; Vita Manzoli; Alice A Tomei; Cherie L Stabler Journal: Biotechnol Bioeng Date: 2017-09-19 Impact factor: 4.530
Authors: Ping Xu; Yougui Wu; Yiliang Zhu; Getachew Dagne; Giffe Johnson; David Cuthbertson; Jeffrey P Krischer; Jay M Sosenko; Jay S Skyler Journal: Diabetes Care Date: 2010-08-31 Impact factor: 19.112
Authors: Lynda E Polgreen; William Thomas; Margaret L MacMillan; John E Wagner; Antoinette Moran; Anna Petryk Journal: Pediatr Blood Cancer Date: 2009-08 Impact factor: 3.167
Authors: Farah A Meah; Linda A DiMeglio; Carla J Greenbaum; Janice S Blum; Jay M Sosenko; Alberto Pugliese; Susan Geyer; Ping Xu; Carmella Evans-Molina Journal: Diabetologia Date: 2016-03-19 Impact factor: 10.122